Brookfield Corporation (BN) Stock Analysis
Score BCyclical · Grade D · Bullish
$45.21
$58.77
+30.0%
5/10
D
Cyclical
Investment Thesis
Price is above modeled value range. Quality supports holding but not attractive for new positions.
Appears undervalued but quality concerns keep the score lower.
For New Investors
Price above modeled value range
For Current Holders
Quantitative score: neutral
Buy if
- Price drops 15-20% (improves asymmetry)
- Bull scenario catalysts materialize
- Market-wide correction creates opportunity
Sell if
- Bear scenario triggers occur
- Quality metrics deteriorate (ROIC declining)
- Better alternatives emerge
Valuation
Fair Value estimate: $58.77 (+30.0%). Significantly undervalued.
PEG-Based EPS
$58.77
FCF DCF Model
$58.77
Blended Fair Value
$58.77
Confidence
High
Methods
PEG-Based EPS, FCF 2-Stage DCF
Quality Analysis
54/120 points
Low Quality
ROE (3Y Avg)
2.2%
ROIC-WACC Spread
-2.8%
D/E Ratio
6.5x
Current Ratio
1.1x
Interest Coverage
1x
FCF Positive Years
0/3
Quality Flags
- Financial sector: alternative quality assessment applied
- Limited revenue history
Market Sentiment
Wall Street Consensus
$60.00
+32.7% Upside
10 analysts
Range: $49.00 — $61.00
Rating: none
Our model aligns with Wall Street consensus.
Trend & Technical
Price ($45.21) is 0.6% above SMA 200 ($44.94). Bullish trend confirmed.
Tech Score 83/100 — Strong technical setup. Trend, momentum, and positioning aligned bullish.
Risk & Reward
Asymmetry Ratio
10.00:1
Expected Return
+67.1%
Bull Upside
+164.9%
Bear Downside
-10.0%
Excellent asymmetry: >3:1 ratio. Upside significantly outweighs downside.
Verdict: Very Favorable
Scenario Analysis
Bear
Base
Bull
Buy Zone & Action Plan
See exact entry zones, stop-loss levels, and a personalized action plan.
AI Executive Summary
Get a detailed AI-written breakdown of the investment thesis, risks, and catalysts.
Technical Analysis
RSI, MACD, moving averages, trend signals, and momentum indicators.
Ask AI about this stock
Chat with our AI analyst to ask questions about valuation, risks, or comparisons.
Frequently Asked Questions
What is the fair value of BN?
Based on our multi-method conviction analysis, the estimated fair value of Brookfield Corporation (BN) is $58.77. This is calculated by blending PEG-Based EPS, FCF 2-Stage DCF and applying a quality premium of 0% based on the company's fundamentals. The confidence level of this estimate is high.
Is BN a buy, sell, or hold?
BN currently has a HOLD rating with a conviction score of 5/10. Price is above modeled value range. Quality supports holding but not attractive for new positions. Price above modeled value range.
Is BN a high-quality stock?
Brookfield Corporation has a quality grade of D (54/120 points), rated as Low Quality. Key metrics include ROE of 2.2%, ROIC-WACC spread of -2.8%, and D/E ratio of 6.5x.
What type of stock is BN?
BN is classified as a "cyclical" in our framework. High P/E: 88.7x, Low dividend (reinvesting): 0.6%, Mature growth: -8.3%, High debt: D/E 6.5x, High beta (cyclical behavior): 1.84
What do Wall Street analysts say about BN?
10 Wall Street analysts have a consensus price target of $60.00 for BN, representing +32.7% upside. Targets range from $49.00 to $61.00. The consensus recommendation is "none". Our model aligns with Wall Street consensus.
What are the risks of investing in BN?
The risk/reward asymmetry ratio for BN is 10.00:1, rated as Very Favorable. Excellent asymmetry: >3:1 ratio. Upside significantly outweighs downside. The expected return is +67.1%, with bull case upside of +164.9% and bear case downside of -10.0%.
What is the current trend for BN?
BN is in a bullish trend. Price ($45.21) is 0.6% above SMA 200 ($44.94). Bullish trend confirmed. The technical score is 83/100.
Related Stock Analyses
Best Stocks to Buy
Get the complete analysis
Scenario targets, buy zones, action plan, executive summary, technical analysis, and AI chat. All free.
Last updated: June 15, 2026 · Framework version 3.7
This analysis is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions.